LIVE FROM THE DATABASETRANSACTIONS 362,430COMPANIES 5,763LATEST TRADE Oct 16UPDATED Oct 17, 12:31 AM

Reporting ownerCIK 0001817160

Gwenn Hansen

40 transactions in one company, from January 30, 2026 to October 15, 2026.

Transactions: 401 company
Bought · P: $0open market
Sold · S: $615Kopen market
Net: −$615Knet selling

By company

Where this insider traded.

Company	Ticker	Trades	Bought	Sold
Nurix Therapeutics, Inc.	NRIX	40	—	$615K

All transactions

40 in total, newest filings first.

Company	Ticker	Insider	Date	Code	Shares	Price	Value
Nurix Therapeutics, Inc.	NRIX	Gwenn HansenChiefDERIV	Oct 15	MPLAN	1,452	$0.00	—?
Nurix Therapeutics, Inc.	NRIX	Gwenn HansenChief	Oct 15	SPLAN	1,452	$25.00	$36K
Nurix Therapeutics, Inc.	NRIX	Gwenn HansenChief	Oct 15	MPLAN	1,452	$1.86	$3K
Nurix Therapeutics, Inc.	NRIX	Gwenn HansenChiefDERIV	Sep 1	MPLAN	1,452	$0.00	—?
Nurix Therapeutics, Inc.	NRIX	Gwenn HansenChief	Sep 1	SPLAN	1,452	$25.47	$37K
Nurix Therapeutics, Inc.	NRIX	Gwenn HansenChief	Sep 1	MPLAN	1,452	$1.86	$3K
Nurix Therapeutics, Inc.	NRIX	Gwenn HansenChiefDERIV	Aug 5	MPLAN	4,356	$0.00	—?
Nurix Therapeutics, Inc.	NRIX	Gwenn HansenChief	Aug 5	SPLAN	4,356	$25.00	$109K
Nurix Therapeutics, Inc.	NRIX	Gwenn HansenChief	Aug 5	MPLAN	4,356	$1.86	$8K
Nurix Therapeutics, Inc.	NRIX	Gwenn HansenChief	Aug 4	SPLAN	2,611	$24.64	$64K
Nurix Therapeutics, Inc.	NRIX	Gwenn HansenChief	Aug 4	SPLAN	1,500	$23.87	$36K
Nurix Therapeutics, Inc.	NRIX	Gwenn HansenChiefDERIV	Jul 30	M	3,572	$0.00	—?
Nurix Therapeutics, Inc.	NRIX	Gwenn HansenChiefDERIV	Jul 30	M	2,858	$0.00	—?
Nurix Therapeutics, Inc.	NRIX	Gwenn HansenChiefDERIV	Jul 30	M	3,750	$0.00	—?
Nurix Therapeutics, Inc.	NRIX	Gwenn HansenChief	Jul 30	S	3,847	$23.38	$90K
Nurix Therapeutics, Inc.	NRIX	Gwenn HansenChief	Jul 30	M	3,572	$0.00	—
Nurix Therapeutics, Inc.	NRIX	Gwenn HansenChief	Jul 30	M	2,858	$0.00	—
Nurix Therapeutics, Inc.	NRIX	Gwenn HansenChief	Jul 30	M	3,750	$0.00	—
Nurix Therapeutics, Inc.	NRIX	Gwenn HansenChief	Jun 25	SPLAN	5,394	$20.00	$108K
Nurix Therapeutics, Inc.	NRIX	Gwenn HansenChiefDERIV	Apr 30	M	2,858	$0.00	—?
Nurix Therapeutics, Inc.	NRIX	Gwenn HansenChiefDERIV	Apr 30	M	3,750	$0.00	—?
Nurix Therapeutics, Inc.	NRIX	Gwenn HansenChiefDERIV	Apr 30	M	2,000	$0.00	—?
Nurix Therapeutics, Inc.	NRIX	Gwenn HansenChief	Apr 30	S	3,214	$16.65	$53K
Nurix Therapeutics, Inc.	NRIX	Gwenn HansenChief	Apr 30	M	2,858	$0.00	—
Nurix Therapeutics, Inc.	NRIX	Gwenn HansenChief	Apr 30	M	3,750	$0.00	—
Nurix Therapeutics, Inc.	NRIX	Gwenn HansenChief	Apr 30	M	2,000	$0.00	—
Nurix Therapeutics, Inc.	NRIX	Gwenn HansenChiefDERIV	Feb 10	A	42,875	$0.00	—?
Nurix Therapeutics, Inc.	NRIX	Gwenn HansenChiefDERIV	Feb 10	A	93,750	$0.00	—?
Nurix Therapeutics, Inc.	NRIX	Gwenn HansenChiefDERIV	Feb 3	M	31,333	$0.00	—?
Nurix Therapeutics, Inc.	NRIX	Gwenn HansenChief	Feb 3	M	31,333	$0.84	$26K
Nurix Therapeutics, Inc.	NRIX	Gwenn HansenChiefDERIV	Jan 30	M	2,859	$0.00	—?
Nurix Therapeutics, Inc.	NRIX	Gwenn HansenChiefDERIV	Jan 30	M	3,750	$0.00	—?
Nurix Therapeutics, Inc.	NRIX	Gwenn HansenChiefDERIV	Jan 30	M	2,000	$0.00	—?
Nurix Therapeutics, Inc.	NRIX	Gwenn HansenChiefDERIV	Jan 30	M	3,207	$0.00	—?
Nurix Therapeutics, Inc.	NRIX	Gwenn HansenChief	Jan 30	S	98	$17.37	$2K
Nurix Therapeutics, Inc.	NRIX	Gwenn HansenChief	Jan 30	S	4,797	$16.58	$80K
Nurix Therapeutics, Inc.	NRIX	Gwenn HansenChief	Jan 30	M	2,859	$0.00	—
Nurix Therapeutics, Inc.	NRIX	Gwenn HansenChief	Jan 30	M	3,750	$0.00	—
Nurix Therapeutics, Inc.	NRIX	Gwenn HansenChief	Jan 30	M	2,000	$0.00	—
Nurix Therapeutics, Inc.	NRIX	Gwenn HansenChief	Jan 30	M	3,207	$0.00	—